HB0043

DRUG3 trials

Sponsors

Shanghai Huaota Biopharmaceutical Co., Ltd.

Conditions

Acne VulgarisHealthyHidradenitis Suppurativa

Phase 1

Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.

RecruitingNCT06895499

Shanghai Huaota Biopharmaceutical Co., Ltd.Hidradenitis Suppurativa

Start: 2025-03-19End: 2026-03-30Target: 15Updated: 2026-01-07

A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants

CompletedNCT06999083

Shanghai Huaota Biopharmaceutical Co., Ltd.Healthy

Start: 2025-06-03End: 2026-04-30Updated: 2026-06-17

A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.

Not yet recruitingNCT07449156

Shanghai Huaota Biopharmaceutical Co., Ltd.Acne Vulgaris

Start: 2026-03-27End: 2027-03-27Target: 21Updated: 2026-03-04